Baolingbao Biology Co.,Ltd. (SHE:002286)

Baolingbao Biology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,685	2,392	2,516	2,713	2,755	2,041
Other Revenue	9.45	9.46	7.65	-	9.9	13.19
Revenue	2,695	2,402	2,524	2,713	2,765	2,055
Revenue Growth (YoY)	12.64%	-4.84%	-6.96%	-1.89%	34.58%	13.82%
Cost of Revenue	2,348	2,123	2,326	2,404	2,397	1,868
Gross Profit	346.37	278.47	197.52	308.4	368.24	186.77
Selling, General & Admin	128.16	106.05	106.5	129.8	122.17	105.09
Research & Development	14.53	9.54	11.3	8.46	12.58	11.2
Other Operating Expenses	7.01	15.66	15.74	15.95	16.33	13.79
Operating Expenses	153.67	134.77	137.74	151.82	155.21	131.41
Operating Income	192.7	143.7	59.78	156.58	213.03	55.37
Interest Expense	-3.12	-13.04	-22.68	-26.54	-16.95	-13.18
Interest & Investment Income	1.4	6.9	7.36	7.97	18.85	8.35
Currency Exchange Gain (Loss)	2.77	6.64	1.61	12.17	-4.28	-6.71
Other Non Operating Income (Expenses)	-2.57	1.92	-3.09	-1.53	0.92	2.35
EBT Excluding Unusual Items	193.53	146.12	42.98	148.65	211.58	46.18
Gain (Loss) on Sale of Investments	-	-	-	2.61	11.23	-
Gain (Loss) on Sale of Assets	0	0.41	-0.05	-0.05	-	-0.07
Asset Writedown	-23.96	-22.56	0.01	-2.32	0.83	-0.07
Other Unusual Items	1.17	7.15	22.17	7.79	13.09	13.59
Pretax Income	170.76	131.11	65.11	156.69	236.74	59.63
Income Tax Expense	26.67	19.95	11.15	23.52	35.16	9.77
Earnings From Continuing Operations	144.09	111.16	53.97	133.17	201.58	49.86
Net Income	144.09	111.16	53.97	133.17	201.58	49.86
Net Income to Common	144.09	111.16	53.97	133.17	201.58	49.86
Net Income Growth	32.13%	105.97%	-59.47%	-33.94%	304.27%	41.52%
Shares Outstanding (Basic)	369	371	360	370	373	356
Shares Outstanding (Diluted)	369	371	360	370	373	356
Shares Change (YoY)	4.48%	2.99%	-2.74%	-0.91%	4.81%	1.08%
EPS (Basic)	0.39	0.30	0.15	0.36	0.54	0.14
EPS (Diluted)	0.39	0.30	0.15	0.36	0.54	0.14
EPS Growth	26.46%	100.00%	-58.33%	-33.33%	285.71%	40.00%
Free Cash Flow	102.37	58.79	130.05	-223.72	113.42	266.53
Free Cash Flow Per Share	0.28	0.16	0.36	-0.60	0.30	0.75
Dividend Per Share	0.060	0.095	0.080	0.080	0.060	0.060
Dividend Growth	-47.83%	18.75%	-	33.33%	-	100.00%
Gross Margin	12.85%	11.59%	7.83%	11.37%	13.32%	9.09%
Operating Margin	7.15%	5.98%	2.37%	5.77%	7.70%	2.70%
Profit Margin	5.35%	4.63%	2.14%	4.91%	7.29%	2.43%
Free Cash Flow Margin	3.80%	2.45%	5.15%	-8.25%	4.10%	12.97%
EBITDA	311.07	261.84	177.62	258.01	318.01	151.63
EBITDA Margin	11.54%	10.90%	7.04%	9.51%	11.50%	7.38%
D&A For EBITDA	118.37	118.14	117.84	101.43	104.98	96.26
EBIT	192.7	143.7	59.78	156.58	213.03	55.37
EBIT Margin	7.15%	5.98%	2.37%	5.77%	7.70%	2.70%
Effective Tax Rate	15.62%	15.22%	17.12%	15.01%	14.85%	16.38%
Revenue as Reported	568.31	2,402	2,524	2,713	2,765	2,055
Advertising Expenses	-	1.87	2.62	2.64	1.15	1.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.